Insights in Gynecologic Oncology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Opinion   
  • Current Trends Gynecol Oncol : 7, Vol 7(5)
  • DOI: 10.4172/ctgo.1000130

A Brief Discussion on Primary Fallopian Tube Carcinoma

Stephanie Ricci*
School of Biosciences, Faculty of Medical and Health Sciences, Taylor's University, 47500 Subang Jaya, Selangor Darul Ehsan, Malaysia
*Corresponding Author : Stephanie Ricci, School of Biosciences, Faculty of Medical and Health Sciences, Taylor's University, 47500 Subang Jaya, Selangor Darul Ehsan, Malaysia, Email: Stephanie_Ma@gmail.com

Received Date: Oct 02, 2022 / Published Date: Oct 31, 2022

Abstract

Primary fallopian tube melanoma (PFTC) is a veritably rare gynecologic nasty excrescence and accounts for roughly 0.14-1.8 of womanish genital malice. In 1847, Renaud first described fallopian tube malice. In 1888, Orthmann presented the first genuine case report. Since also over 2000 case have been reported in literature. Its prevalence has been rising during the last decades and varied between 2.9 and 5.7. Histologic, molecular and inheritable substantiation shows that from 40-60 of tumors that were classified as high-grade serous lymphomas of the ovary or peritoneum may have begun in the fimbria and of the fallopian tube. Thus the prevalence of fallopian tube cancers may have been undervalued.

Citation: Ricci S (2022) A Brief Discussion on Primary Fallopian Tube Carcinoma. Current Trends Gynecol Oncol, 7: 130. Doi: 10.4172/ctgo.1000130

Copyright: © 2022 Ricci S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top